229 related articles for article (PubMed ID: 30728019)
1. The role of recombinant LH in women with hypo-response to controlled ovarian stimulation: a systematic review and meta-analysis.
Conforti A; Esteves SC; Di Rella F; Strina I; De Rosa P; Fiorenza A; Zullo F; De Placido G; Alviggi C
Reprod Biol Endocrinol; 2019 Feb; 17(1):18. PubMed ID: 30728019
[TBL] [Abstract][Full Text] [Related]
2. Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged ≥35 years: a randomized controlled trial.
Vuong TN; Phung HT; Ho MT
Hum Reprod; 2015 May; 30(5):1188-95. PubMed ID: 25740882
[TBL] [Abstract][Full Text] [Related]
3. The use of recombinant luteinizing hormone in patients undergoing assisted reproductive techniques with advanced reproductive age: a systematic review and meta-analysis.
Hill MJ; Levens ED; Levy G; Ryan ME; Csokmay JM; DeCherney AH; Whitcomb BW
Fertil Steril; 2012 May; 97(5):1108-14.e1. PubMed ID: 22365075
[TBL] [Abstract][Full Text] [Related]
4. A comparison of outcomes from in vitro fertilization cycles stimulated with either recombinant luteinizing hormone (LH) or human chorionic gonadotropin acting as an LH analogue delivered as human menopausal gonadotropins, in subjects with good or poor ovarian reserve: a retrospective analysis.
Dahan MH; Agdi M; Shehata F; Son W; Tan SL
Eur J Obstet Gynecol Reprod Biol; 2014 Jan; 172():70-3. PubMed ID: 24314801
[TBL] [Abstract][Full Text] [Related]
5. Recombinant luteinizing hormone supplementation to recombinant follicle-stimulation hormone during induced ovarian stimulation in the GnRH-agonist protocol: a meta-analysis.
Oliveira JB; Mauri AL; Petersen CG; Martins AM; Cornicelli J; Cavanha M; Pontes A; Baruffi RL; Franco JG
J Assist Reprod Genet; 2007; 24(2-3):67-75. PubMed ID: 17195098
[TBL] [Abstract][Full Text] [Related]
6. Clinical effects of ovulation induction with recombinant follicle-stimulating hormone supplemented with recombinant luteinizing hormone or low-dose recombinant human chorionic gonadotropin in the midfollicular phase in microdose cycles in poor responders.
Berkkanoglu M; Isikoglu M; Aydin D; Ozgur K
Fertil Steril; 2007 Sep; 88(3):665-9. PubMed ID: 17292895
[TBL] [Abstract][Full Text] [Related]
7. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
[TBL] [Abstract][Full Text] [Related]
8. Retrospective analysis of treatments with recombinant FSH and recombinant LH versus human menopausal gonadotropin in women with reduced ovarian reserve.
Mignini Renzini M; Brigante C; Coticchio G; Dal Canto M; Caliari I; Comi R; De Ponti E; Fadini R
J Assist Reprod Genet; 2017 Dec; 34(12):1645-1651. PubMed ID: 28871409
[TBL] [Abstract][Full Text] [Related]
9. The evaluation of recombinant LH supplementation in patients with suboptimal response to recombinant FSH undergoing IVF treatment with GnRH agonist down-regulation.
Yazıcı Yılmaz F; Görkemli H; Çolakoğlu MC; Aktan M; Gezginç K
Gynecol Endocrinol; 2015 Feb; 31(2):141-4. PubMed ID: 25237892
[TBL] [Abstract][Full Text] [Related]
10. Lower apoptosis rate in human cumulus cells after administration of recombinant luteinizing hormone to women undergoing ovarian stimulation for in vitro fertilization procedures.
Ruvolo G; Bosco L; Pane A; Morici G; Cittadini E; Roccheri MC
Fertil Steril; 2007 Mar; 87(3):542-6. PubMed ID: 17126339
[TBL] [Abstract][Full Text] [Related]
11. Recombinant LH administration in subsequent cycle after "unexpected" poor response to recombinant FSH monotherapy.
Papaleo E; Vanni VS; Viganò P; La Marca A; Pagliardini L; Vitrano R; Zanirato M; Marsiglio E; Privitera L; Candiani M
Gynecol Endocrinol; 2014 Nov; 30(11):813-6. PubMed ID: 24968088
[TBL] [Abstract][Full Text] [Related]
12. Controlled Ovarian Stimulation with recombinant-FSH plus recombinant-LH vs. human Menopausal Gonadotropin based on the number of retrieved oocytes: results from a routine clinical practice in a real-life population.
Revelli A; Pettinau G; Basso G; Carosso A; Ferrero A; Dallan C; Canosa S; Gennarelli G; Guidetti D; Filippini C; Benedetto C
Reprod Biol Endocrinol; 2015 Jul; 13():77. PubMed ID: 26209525
[TBL] [Abstract][Full Text] [Related]
13. Does exogenous LH in ovarian stimulation improve assisted reproduction success? An appraisal of the literature.
Hill MJ; Levy G; Levens ED
Reprod Biomed Online; 2012 Mar; 24(3):261-71. PubMed ID: 22285265
[TBL] [Abstract][Full Text] [Related]
14. Recombinant luteinizing hormone priming in multiple follicular stimulation for in-vitro fertilization in downregulated patients.
Lisi F; Caserta D; Montanino M; Berlinghieri V; Bielli W; Carfagna P; Carra MC; Costantino A; Lisi R; Poverini R; Ciardo F; Rago R; Marci R; Moscarini M
Gynecol Endocrinol; 2012 Sep; 28(9):674-7. PubMed ID: 22313135
[TBL] [Abstract][Full Text] [Related]
15. WITHDRAWN: Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction cycles.
Daya S; Gunby J
Cochrane Database Syst Rev; 2007 Jul; 2006(3):CD002810. PubMed ID: 17636708
[TBL] [Abstract][Full Text] [Related]
16. Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction cycles.
Daya S; Gunby J
Cochrane Database Syst Rev; 2000; (4):CD002810. PubMed ID: 11034767
[TBL] [Abstract][Full Text] [Related]
17. Recombinant human luteinizing hormone co-treatment in ovarian stimulation for assisted reproductive technology in women of advanced reproductive age: a systematic review and meta-analysis of randomized controlled trials.
Conforti A; Esteves SC; Humaidan P; Longobardi S; D'Hooghe T; Orvieto R; Vaiarelli A; Cimadomo D; Rienzi L; Ubaldi FM; Zullo F; Alviggi C
Reprod Biol Endocrinol; 2021 Jun; 19(1):91. PubMed ID: 34154604
[TBL] [Abstract][Full Text] [Related]
18. Results of controlled ovarian stimulation for ART in poor responders according to the short protocol using different gonadotrophins combinations.
Loutradis D; Elsheikh A; Kallianidis K; Drakakis P; Stefanidis K; Milingos S; Michalas S
Arch Gynecol Obstet; 2004 Dec; 270(4):223-6. PubMed ID: 13680266
[TBL] [Abstract][Full Text] [Related]
19. Recombinant luteinizing hormone supplementation in assisted reproductive technology: a systematic review.
Alviggi C; Conforti A; Esteves SC; Andersen CY; Bosch E; Bühler K; Ferraretti AP; De Placido G; Mollo A; Fischer R; Humaidan P;
Fertil Steril; 2018 Apr; 109(4):644-664. PubMed ID: 29653717
[TBL] [Abstract][Full Text] [Related]
20. Role of LH and FSH in ovarian function.
Howles CM
Mol Cell Endocrinol; 2000 Mar; 161(1-2):25-30. PubMed ID: 10773387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
